Publications by authors named "Mogens Groenvold"

Introduction: In 2020, the Danish National Audit Office (Rigsrevisionen) criticised the Danish palliative care (PC) provision. The Board of the Danish Association for Palliative Medicine (DSPaM) recognised an urgent need for a national strategy to improve PC in Denmark. The Board wished to develop a strategy which ensured acceptance and legitimation internationally and within the DSPaM.

View Article and Find Full Text PDF

Introduction: Cancer and cancer treatment have a major impact on health related quality of life (HRQoL). To improve the assessment of HRQoL in patients with cancer and evaluate the impact of policy interventions, the European Oncology Quality of Life (EUonQoL) project aims at developing a digital, patient centred system to assess HRQoL based on evaluations and preferences of cancer patients and survivors: the EUonQoL-kit.

Method: Patients across the cancer care continuum, healthcare professionals and researchers from six European countries (Denmark, France, Germany, Italy, The Netherlands and United Kingdom) were asked to rate the importance of 44 pre-selected HRQoL subdomains over a maximum of three Delphi survey rounds.

View Article and Find Full Text PDF

Background: The EORTC QLQ-F17, a shortened version of the EORTC QLQ-C30, solely contains the items related to functioning and omits symptom scales. The QLQ-F17 is conceived an equivalent to the functional part of the QLQ-C30, but to date there is no empirical evidence to support this rationale.

Methods: This randomized, cross-over, multi-national, questionnaire-based study investigates the equivalence and psychometric properties of the QLQ-F17 compared to the functional scales of the QLQ-C30.

View Article and Find Full Text PDF

Introduction: There is a general need for sharing practical examples of Patient and Public Involvement (PPI) within the research field to learn from and inspire. The aim of this article is to describe our process evaluation of PPI within the development process of the EUonQoL-Kit, a new set of quality of life questionnaires aimed at people with (past experience of) cancer.

Methods: Five co-researchers (people with cancer and informal caregivers) were recruited and received training and support from a dedicated team of researchers.

View Article and Find Full Text PDF

Background: A pooled data analysis by Quinten et al. (2009) found three European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) health-related quality of life (HRQoL) scales to be prognostic for survival: physical functioning, pain and appetite loss. This study aims to replicate these findings in an independent data set comprising a broader cancer population.

View Article and Find Full Text PDF

The development of the first European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group (QLG) health-related quality of life (HRQoL) questionnaires contributed to the systematic uptake of HRQoL as an endpoint in cancer clinical trials, and to the measurement of HRQoL for individual assessment in routine care. Following a modular approach, these patient-reported outcome (PRO) measures (PROMs) ensure that both generic and disease-specific issues are assessed, enabling comparison of PROs across groups and studies. The application of a comprehensive and continually refined methodology for developing and updating these PROMs has been crucial in supporting their psychometric and cross-cultural validity, and their continued implementation in clinical research.

View Article and Find Full Text PDF

Background: Cancer treatment greatly impacts physical and psychological functioning of cancer patients, negatively affecting their quality of life (QoL). This Umbrella Review (UR) aims to systematically summarize psychological and social factors positively or negatively associated with QoL in cancer patients undergoing treatment.

Method: Four scientific databases (PubMed, Embase, Scopus, and PsycInfo) were searched to identify systematic reviews between 2012 and 2023 analyzing the relationship between QoL and psychosocial factors in cancer patients in treatment.

View Article and Find Full Text PDF

Introduction: Over the past decades, there has been increasing recognition that assessing patients with cancer's health-related quality of life (HRQoL) is pivotal to delivering optimal patient-centred healthcare. However, with the increasing number of patient-reported outcome measures (PROMs) available, it becomes more and more challenging to identify the most appropriate PROM to capture HRQoL. Therefore, the aim of this systematic review is to (1) identify all available PROMs assessing HRQoL across the European cancer continuum and (2) critically appraise, compare and summarise the psychometric properties of the identified PROMs.

View Article and Find Full Text PDF

Background: Computerized adaptive test (CAT) provides individualized measurement, using the patient's previous responses to select the next most informative item. However, the first item, the start item, is usually not individualized as no score estimate is available a priori. The European Organisation for Research and Treatment of Cancer (EORTC) CAT Core covers 15 health-related quality of life domains.

View Article and Find Full Text PDF

Purpose: To systematically review qualitative studies on outcomes, needs, experiences, preferences, concerns and health-related quality of life (HRQoL) of people surviving cancer in Europe in the last decade.

Methods: Protocol registered ( https://www.crd.

View Article and Find Full Text PDF

Background: To assess fatigue in cancer patients, several patient-reported outcome measures (PROMs) are available that differ in content. To support the selection of suitable measures for specific applications and to evaluate possibilities of quantitative linking, the present study provides a content comparison of common fatigue measures, scales, and item banks. We included the EORTC CAT Core, EORTC QLQ-FA12, EORTC QLQ-C30, FACIT-F, PROMIS Fatigue (Cancer item bank v1.

View Article and Find Full Text PDF

Background: Sentinel lymph node mapping is a minimally invasive surgical staging procedure that allows identification of macro- and micrometastases. The implementation of sentinel lymph node mapping to women with low-grade endometrial cancer allows detection of lymph node metastases and avoids the morbidity of radical pelvic lymphadenectomy. The extent of myometrial invasion is highly predictive of lymph node metastases but is hard to determine precisely preoperatively.

View Article and Find Full Text PDF

Background: Patients with non-cancer disease are less likely to receive specialized palliative care than cancer patients. To be able to provide the best specialized palliative care, it is important to understand palliative care needs of non-cancer patients and whether the type and level of needs differ from those of cancer patients. Large studies including both cancer and non-cancer patients, using validated needs-assessment-tools, are needed to understand differences in palliative care needs at admittance to specialized palliative care.

View Article and Find Full Text PDF

Background: Patient and public involvement (PPI) has become an essential part of health research. There is a need for genuine involvement in order to ensure that research is relevant to patients. This can then improve the quality, relevance, and impact of health research, while at the same time reducing wasted research and in doing so bringing science and society closer together.

View Article and Find Full Text PDF
Article Synopsis
  • - The Danish Palliative Care Database has five key quality indicators measuring the effectiveness of palliative care for patients referred for specialized support from 2010 to 2020.
  • - A study analyzed changes in these indicators over the decade, revealing an increase in non-cancer patients receiving care but a decline in timely contact within 10 days of referral.
  • - Overall, while improvements were noted in most indicators, the waiting time issue persists, indicating a need for better palliative care, particularly for non-cancer patients in Denmark.
View Article and Find Full Text PDF
Article Synopsis
  • The study evaluates the WISP (Write In three Symptoms/Problems) tool, which allows cancer patients to report additional symptoms not covered by standard questionnaires, aiming to improve symptom recognition during active and palliative care.
  • Conducted across several countries, the research involved translating and pilot testing the instrument, interviewing patients, and analyzing their responses to gauge understanding and acceptability.
  • Results from the study indicated high acceptability of WISP among patients, with findings revealing different prevalent symptoms based on treatment status, supporting WISP’s recommendation for use alongside existing EORTC questionnaires for comprehensive symptom assessment.
View Article and Find Full Text PDF

Purpose: Since 2010, a comprehensive symptom/problem (S/P) assessment has been carried out in Danish specialist palliative care using the EORTC QLQ-C15-PAL questionnaire and the open-ended "Write In three Symptoms/Problems" (WISP) instrument. On WISP patients can report up to three S/Ps not included in the EORTC QLQ-C15-PAL. However, little is known about which S/Ps patients with non-cancer diseases report using WISP.

View Article and Find Full Text PDF

Aims: Computerised adaptive test (CAT) provides individualised patient reported outcome measurement while retaining direct comparability of scores across patients and studies. Optimal CAT measurement requires an appropriate CAT-setting, the set of criteria defining the CAT including start item, item selection criterion, and stop criterion. The European Organisation for Research and Treatment of Cancer (EORTC) CAT Core allows for assessing the 14 functional and symptom domains covered by the EORTC QLQ-C30 questionnaire.

View Article and Find Full Text PDF

Objective: To provide equipercentile equating of physical function (PF) scores from frequently used patient-reported outcome measures (PROMs) in cancer patients to facilitate data pooling and comparisons.

Study Design And Setting: Adult cancer patients from five European countries completed the European Organization for Research and Treatment of Cancer (EORTC) computer adaptive test (CAT) Core, EORTC Quality of Life Questionnaire Version 3.0 (QLQ-C30), Functional Assessment of Cancer Therapy - General (FACT-G), 36-item Short Form Health Survey (SF-36), and the Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function 20a short form.

View Article and Find Full Text PDF

Purpose: We investigated the association between health-related quality of life (HRQL) and the severity of hypothyroidism at diagnosis in patients referred to a secondary hospital clinic.

Methods: Sixty-seven adult patients referred from primary care were enrolled. All patients had newly diagnosed hypothyroidism due to autoimmune thyroiditis and were treated with levothyroxine (LT4).

View Article and Find Full Text PDF
Article Synopsis
  • The study examines how patient-reported outcome (PRO) measures assess role functioning (RF) and social functioning (SF) in cancer patients, aligning with the World Health Organization’s definition of health.
  • It analyzes various PRO measures, including the EORTC and FACT-G, linking their content to the International Classification of Functioning, Disability and Health (ICF) framework.
  • The findings reveal both overlaps and distinctions in what these measures cover regarding social health, providing insights for selecting the most suitable measurement tools for specific research or clinical contexts.
View Article and Find Full Text PDF
Article Synopsis
  • Early guidelines set a minimally important difference (MID) of ≥10 points for the EORTC QLQ-C30, but evidence suggests that MIDs vary based on scale, type of cancer, and other factors, questioning the validity of a universal standard.
  • This study analyzed data from 21 EORTC Phase III trials involving 13,015 patients across nine different cancer types to identify pattern differences in MIDs for within- and between-group changes over time.
  • Results showed that anchor-based MIDs typically ranged from 5 to 10 points, with notable variations based on scale and cancer type, highlighting the need for researchers to consider specific contexts rather than relying on a one-size-fits-all MID approach.
View Article and Find Full Text PDF